Perspectives of nanotechnology in minimally invasive therapy of breast cancer

Journal of Healthcare Engineering

Volumn 4, Issue 1, 2013, Pages 67-86

  Yang, Yamin ^a   Wang, Hongjun ^a  

^a Stevens Institute of Technology   (United States)

Author keywords

Breast cancer; Minimally invasive therapy; Nanoparticles

Indexed keywords

CELLS; DRUG INTERACTIONS; NANOPARTICLES;

BREAST CANCER; CANCER CELLS; CANCER THERAPY; INVASIVENESS; MINIMALLY INVASIVE; MINIMALLY INVASIVE THERAPY; SURGICAL EXCISION; THERAPEUTIC DRUGS;

DISEASES;

NANOCAPSULE;

ABLATION THERAPY; BREAST TUMOR; FEMALE; HUMAN; METHODOLOGY; MINIMALLY INVASIVE SURGERY; NANOMEDICINE; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; REVIEW;

ABLATION TECHNIQUES; BREAST NEOPLASMS; FEMALE; HUMANS; NANOCAPSULES; NANOMEDICINE; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

MLCS; MLOWN;

EID: 84874906112     PISSN: 20402295     EISSN: 20402309     Source Type: Journal    
DOI: 10.1260/2040-2295.4.1.67     Document Type: Review

References (118)

1. What are the key statistics about breast cancer? http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics, Accessed December 05, 2012.
2. Heneghan HM, Prichard RS, Devaney A, Sweeney KJ, Malone C, McLaughlin R, Kerin MJ. Evolution of breast cancer management in Ireland: a decade of change. BMC surgery, 2009, 9:15.
3. Loprinzi PD, Cardinal BJ. Effects of physical activity on common side effects of breast cancer treatment. Breast cancer, 2012, 19:4-10.
4. Noguchi M. Minimally invasive surgery for small breast cancer. Journal of surgical oncology, 2003, 84:94-101.
5. Singletary SEVA. Minimally invasive techniques in breast. Seminars in Surgical Oncology, 2001, 20(3):246-250.
6. Hung WK, Ying M, Chan CM, Lam HS, Mak KL. Minimally invasive technology in the management of breast disease. Breast cancer, 2009, 16:23-29.
7. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Advanced drug delivery reviews, 2012, 54:631-651.
8. Choi Y-E, Kwak J-W, Park JW. Nanotechnology for early cancer detection. Sensors, 2010, 10:428-455.
9. Conde J, Doria G, Baptista P. Noble metal nanoparticles applications in cancer. Journal of drug delivery, 2012, 751075.
10. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Advanced drug delivery reviews, 2004, 56:1649-1659.
11. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine: nanotechnology, biology, and medicine, 2005, 1:193-212.
12. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Molecular cancer therapeutics, 2006, 5:1909-1917.
13. Kim K, Kim JH, Park H, Kim Y-S, Park K, Nam H, Lee S, Park JH, Park R-W, Kim I-S, Choi K, Kim SY, Park K, Kwon IC. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. Journal of controlled release, 2010, 146:219-227.
14. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacological research: the official journal of the Italian Pharmacological Society, 2010, 62:90-99.
15. Yu MK, Park J, Jeong YY, Moon WK, Jon S. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery. Nanotechnology, 2010, 21:415102.
16. Torchilin VP. Polymer-coated long-circulating microparticulate pharmaceuticals. Journal of microencapsulation, 1998, 15:1-19.
17. Moore A, Marecos E, Bogdanov A, Weissleder R. Tumoral distribution of iron oxide nanoparticles in a rodent model 1. Radiology, 2000, 214.
18. Moghimi SM, Hunter a C, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological reviews, 2001, 53:283-318.
19. Senthil Kumar P, Pastoriza-Santos I, Rodríguez-González B, Javier García de Abajo F, Liz-Marzán LM. High-yield synthesis and optical response of gold nanostars. Nanotechnology, 2008, 19:015606.
20. Principe L, D'Arezzo S, Capone A, Petrosillo N, Visca P. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Annals of clinical microbiology and antimicrobials, 2009, 8:18.
21. Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chemical Society reviews, 2012, 41:2885-2911.
22. Waite CL, Roth CM. Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Critical reviews in biomedical engineering, 2012, 40:21-41.
23. Ranganathan R, Madanmohan S, Kesavan A, Baskar G, Krishnamoorthy YR, Santosham R, Ponraju D, Rayala SK, Venkatraman G. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. International journal of nanomedicine, 2012, 7:1043-1060.
24. Heneweer C, Gendy SEM, Peñate-Medina O. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging. Therapeutic delivery, 2012, 3:645-656.
25. Kumar P, Gulbake A, Jain SK. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy. Critical reviews in therapeutic drug carrier systems, 2012, 29:355-419.
26. Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Accounts of chemical research, 2011, 44:1080-1093.
27. Hu C-MJ, Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochemical pharmacology, 2012, 83:1104-1111.
28. Kaminskas LM, McLeod VM, Porter CJH, Boyd BJ. Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation. Molecular pharmaceutics, 2012, 9:355-373.
29. Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert review of clinical pharmacology, 2012, 5:173-186.
30. Tong L, Zhao M, Zhu S, Chen J. Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer. Frontiers of medicine, 2011, 5:379-387.
31. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chemical Society reviews, 2012, 41:2256-2282.
32. Cherukuri P, Curley SA. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells. Methods in molecular biology, 2010, 624:359-373.
33. Abbasi S, Paul A, Shao W, Prakash S. Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment. Journal of drug delivery, 2012, 686108.
34. Lee S-M, O'Halloran TV, Nguyen ST. Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy. Journal of the American Chemical Society, 2010, 132:17130-17138.
35. Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Journal of controlled release: official journal of the Controlled Release Society, 2009, 133:11-17.
36. Yang C, Liu HZ, Fu ZX, Lu WD: Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma. BMC biotechnology, 2011, 11:21.
37. Agrawal P, Strijkers GJ, Nicolay K. Chitosan-based systems for molecular imaging. Advanced drug delivery reviews, 2010, 62:42-58.
38. Taylor RM, Sillerud LO. Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner. International journal of nanomedicine, 2012, 7:4341-4352.
39. Xu L, Pirollo KF, Tang WH, Rait A, Chang EH. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Human gene therapy, 1999, 10:2941-2952.
40. Wu Y, Wang W, Chen Y, Huang K, Shuai X, Chen Q, Li X, Lian G. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. International journal of nanomedicine, 2010, 5:129-136.
41. Daniels TR, Bernabeu E, Rodríguez JA, Patel S, Kozman M, Chiappetta DA, Holler E, Ljubimova JY, Helguera G, Penichet ML. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochimica et biophysica acta, 2012, 1820:291-317.
42. Aydin RST. Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting. Journal of biomedical materials research. Part A, 2012.
43. Mi Y, Liu X, Zhao J, Ding J, Feng S-S. Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials, 2012, 33:7519-7529.
44. Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. European journal of pharmaceutics and biopharmaceutics, 2012, 81:248-256.
45. Fornage BD, Edeiken BS. Percutaneous ablation of breast tumors. Tumor ablation, 2005, 5:428-439.
46. Salagierski M, Salagierski MS. Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management, Cancers. 2010, 2:1895-1900.
47. Habash RWY, Bansal R, Krewski D, Hafi T. Thermal therapy, Part III: ablation, 2007, 35:37-121.
48. Cardinal J, Klune JR, Chory E, Jeyabalan G, Kanzius JS, Nalesnik M, Geller DA. Non-invasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery, 2008, 144:125-132.
49. Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley S. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. Journal of nanobiotechnology, 2008, 6:2.
50. Ho VHB, Smith MJ, Slater NKH. Effect of magnetite nanoparticle agglomerates on the destruction of tumor spheroids using high intensity focused ultrasound. Ultrasound in medicine & biology, 2011, 37:169-175.
51. Sun Y, Zheng Y, Ran H, Zhou Y, Shen H, Chen Y, Chen H, Krupka TM, Li A, Li P, Wang Z, Wang Z. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials, 2012, 33:5854-5864.
52. Yan J-F, Liu J. Nanocryosurgery and its mechanisms for enhancing freezing efficiency of tumor tissues. Nanomedicine: nanotechnology, biology, and medicine, 2008, 4:79-87.
53. Goel R, Swanlund D, Coad J, Paciotti GF, Bischof JC. TNF-alpha-based accentuation in cryoinjurydose, delivery, and response. Molecular cancer therapeutics, 2007, 6:2039-2047.
54. Konan YN, Berton M, Gurny R, Allémann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. European journal of pharmaceutical sciences, 2003, 18:241-249.
55. Ricci-Júnior E, Marchetti JM. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. International journal of pharmaceutics, 2006, 310:187-195.
56. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. Journal of the American Chemical Society, 2003, 125:7860-7865.
57. Wieder ME, Hone DC, Cook MJ, Handsley MM, Gavrilovic J, Russell D. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a "Trojan horse". Photochemical & photobiological sciences, 2006, 5:727-734.
58. Kyaw M, Oo K, Yang X, Du H, Wang H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine, 2008, 3(6):777-786.
59. Khaing Oo MK, Yang Y, Hu Y, Gomez M, Du H, Wang H. Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX. ACS nano. 2012, 6:1939-1947.
60. El-Sayed IH, Huang X, El-Sayed M. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer letters, 2006, 239:129-135.
61. Huang X, Jain PK, El-Sayed IH, El-Sayed M. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers in medical science, 2008, 23:217-28.
62. Carpin LB, Bickford LR, Agollah G, Yu T-K, Schiff R, Li Y, Drezek RA. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells. Breast cancer research and treatment, 2011, 125:27-34.
63. von Maltzahn G, Park J-H, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer research, 2009, 69:3892-3900.
64. Zhou F, Xing D, Ou Z, Wu B, Resasco DE, Chen WR. Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes. Journal of biomedical optics, 2009, 14:021009.
65. Vlastos G, Verkooijen HM. Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer. The oncologist, 2007, 12:1-10.
66. Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, Singletary SE. Radiofrequency ablation of solid tumors. Cancer journal, 2001, 7:95-102.
67. Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, Botti G, D'Aiuto G, Cortino P, Curley SA. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer, 2001, 92:2036-44.
68. Lim Z-ZJ, Li J-EJ, Ng C-T, Yung L-YL, Bay B-H Gold nanoparticles in cancer therapy. Acta pharmacologica Sinica, 2011, 32:983-90.
69. Jain S, Hirst DG, O'Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. The British journal of radiology, 2012, 85:101-113.
70. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine, 2007, 2:681-693.
71. Rippel RA, Seifalian AM. Gold revolution-gold nanoparticles for modern medicine and surgery. Journal of nanoscience and nanotechnology, 2011, 11:3740-3748.
72. Lee S, Chon H, Lee M, Choo J, Shin SY, Lee YH, Rhyu IJ, Son SW, Oh CH. Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres. Biosensors & bioelectronics, 2009, 24:2260-2263.
73. Chattopadhyay N, Cai Z, Pignol J, Keller B, Lechtman E, Bendayan R, Reilly RM. Design and characterization of her-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Mol. Pharmaceutics, 2010, 7(6):2194-2206.
74. Chen L, Bouley D, Yuh E, D'Arceuil H, Butts K. Study of focused ultrasound tissue damage using MRI and histology. Journal of magnetic resonance imaging, 1999, 10:146-153.
75. McDannold, Hynynen K, Wolf D, Wolf G, Jolesz F. MRI evaluation of thermal ablation of tumors with focused ultrasound. Journal of magnetic resonance imaging, 1998, 8:91-100.
76. Cline HE, Hynynen K, Watkins RD, Adams WJ, Schenck JF, Ettinger RH, Freund WR, Vetro JP, Jolesz FA. Focused US system for MR imaging-guided tumor ablation. Radiology, 1995, 194:731-737.
77. Gianfelice D, Khiat A, Amara M, Belblidia A. Radiology MR imaging-guided focused us ablation of breast cancer: histopathologic assessment of effectivenessinitial. Radiology, 2002, 227(3):849-855.
78. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nature reviews. Cancer, 2005, 5:321-327.
79. Li Y-Y, Sha W-H, Zhou Y-J, Nie Y-Q. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. Journal of gastroenterology and hepatology, 2007, 22:2148-2154.
80. Choi S-Y, Kim Y-S, Seo Y-J, Yang J, Choi K-S. Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation. PloS one, 2012, 7:e34333.
81. Theodorescu D. Cancer cryotherapy: evolution and biology. Rev Urol, 2004, 6 Suppl 4:S9-S19.
82. Goel R, Anderson K, Slaton J, Schmidlin F, Vercellotti G, Belcher J, Bischof JC. Adjuvant approaches to enhance cryosurgery. Journal of biomechanical engineering, 2009, 131:074003.
83. Sabel MS, Kaufman CS, Whitworth P, Chang H, Stocks LH, Simmons R, Schultz M. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Annals of surgical oncology, 2004, 11:542-549.
84. Liu J, Deng Z-S. Nano-cryosurgery: advances and challenges. Journal of Nanoscience and Nanotechnology, 2009, 9:4521-4542.
85. Shackley DC, Whitehurst C, Moore JV, Betts C. Photodynamic therapy. Journal of the royal society of medicine, 1999, 92(11): 562-565.
86. Santosa V, Limantara L. Review photodynamic therapy: new light in medicine worlD. Indo. J. Chem, 2008, 8:279-291.
87. Yoon J-H, Yoon H-E, Kim O, Kim SK, Ahn S-G, Kang KW. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells. Lasers in surgery and medicine, 2012, 44:76-86.
88. Montazerabadi A-R, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Shakeri-Zadeh A, Aledavood A. Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer. Photodiagnosis and photodynamic therapy, 2012, 9:46-51.
89. Ahn T-G, Lee B-R, Choi E-Y, Kim DW, Han S-J. Photodynamic therapy for breast cancer in a BALB/c mouse model. Journal of gynecologic oncology, 2012, 23:115-119.
90. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Advanced drug delivery reviews, 2008, 60:1627-1637.
91. Qian J, Wang D, Cai F, Zhan Q, Wang Y, He S. Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging. Biomaterials, 2012, 33:4851-4860.
92. Jia X, Jia L. Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy. Current drug metabolism, 2012.
93. Battah S, Balaratnam S, Casas A, O'Neill S, Edwards C, Batlle A, Dobbin P, MacRobert AJ. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Molecular cancer therapeutics, 2007, 6:876-85.
94. Huang P, Lin J, Yang D, Zhang C, Li Z, Cui D. Photosensitizer-loaded dendrimer-modified multi-walled carbon nanotubes for photodynamic therapy. Journal of controlled release, 2011, 152 Suppl: e33-4.
95. Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochemical & photobiological sciences, 2011, 10:822-831.
96. Kameyama N, Matsuda S, Itano O, Ito A, Konno T, Arai T, Ishihara K, Ueda M, Kitagawa Y. Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study. Cancer biotherapy & radiopharmaceuticals, 2011, 26:697-704.
97. Jang B, Park J, Tung C, Kim I, Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano, 2011, 5(2):1086-1094.
98. Jang B, Choi Y. Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy. Theranostics, 2012, 2:190-197.
99. Kuo W-S, Chang C-N, Chang Y-T, Yang M-H, Chien Y-H, Chen S-J, Yeh C-S. Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angewandte Chemie, 2010, 49:2711-2715.
100. Kah JCY, Wan RCY, Wong KY, Mhaisalkar S, Sheppard CJR, Olivo M. Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: an in vitro study. Lasers in surgery and medicine, 2008, 40:584-589.
101. Day ES, Thompson P, Zhang L, Lewinski N, Ahmed N, Drezek R, Blaney SM, West JL. Nanoshellmediated photothermal therapy improves survival in a murine glioma model. Journal of neurooncology, 2011, 104:55-63.
102. Young JK, Figueroa ER, Drezek R. Tunable nanostructures as photothermal theranostic agents. Annals of biomedical engineering, 2012, 40:438-459.
103. Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL: Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. Journal of neuro-oncology, 2008, 86:165-172.
104. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano letters, 2007, 7:1929-1934.
105. Gobin AM, Watkins EM, Quevedo E, Colvin VL, West L. Near infrared resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small, 2011, 6:745-752.
106. Black KC, Yi J, Rivera JG, Zelasko-Leon DC, Messersmith PB. Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine, 2012.
107. 2 nanotubes in combination with near-infrared laser. Journal of Cancer Therapy, 2010, 01:52-58.
108. Wang X, Wang C, Cheng L, Lee S-T, Liu Z. Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy. Journal of the American Chemical Society, 2012, 134:7414-7422.
109. Liang F, Chen B. A review on biomedical applications of single-walled carbon nanotubes. Current medicinal chemistry, 2010, 17:10-24.
110. Liopo AV, Stewart MP, Hudson J, Tour JM, Pappas TC. Biocompatibility of native and functionalized single-walled carbon nanotubes for neuronal interface. Journal of nanoscience and nanotechnology, 2006, 6:1365-1374.
111. von Maltzahn G, Park J-H, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer research, 2009, 69:3892-3900.
112. Cai W. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnology, Science and Applications, 2008, 1:17-32.
113. Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annual review of biomedical engineering, 2012, 14:1-16.
114. Mithun M. Shenoi, Neha B. Shah, Robert J. Griffin, Gregory M. Vercellotti and JC, Bischof. Nanoparticle pre-conditioning for enhanced thermal therapies in cancer. Nanomedicine, 2011, 6:545-563.
115. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases, 2007, 2:MR17-71.
116. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir, 2005, 21:10644-10654.
117. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small, 2007, 3:1941-1949.
118. Zhang X-D, Wu H-Y, Wu D, Wang Y-Y, Chang J-H, Zhai Z-B, Meng A-M, Liu P-X, Zhang L-A, Fan F-Y. Toxicologic effects of gold nanoparticles in vivo by different administration routes. International journal of nanomedicine, 2010, 5:771-781.